首页 > 最新文献

JMV-Journal de Medecine Vasculaire最新文献

英文 中文
New insights in breast cancer-related lymphedema 淋巴水肿相关乳腺癌的新发现
Q3 Medicine Pub Date : 2024-09-01 DOI: 10.1016/j.jdmv.2024.06.001
Caroline Fourgeaud, Stéphane Vignes

Upper limb lymphedema after breast cancer treatment including axillary dissection occurs in almost 20% of women. Its treatment consists of complete decongestive physiotherapy based on low-stretch bandage to reduce volume, followed by elastic compression to maintain it. In this article, we will detail recent data on lymphedema risk factors with possible genetic predisposition, prevention (surgical, compression), manual lymphatic drainage, physical activity, weight, advice, and treatments including gene therapy.

近 20% 的妇女在接受乳腺癌治疗(包括腋窝切除术)后会出现上肢淋巴水肿。淋巴水肿的治疗包括基于低弹力绷带的彻底消除充血物理疗法,以减少水肿量,然后使用弹力加压疗法来维持水肿。在本文中,我们将详细介绍淋巴水肿风险因素的最新数据,包括可能的遗传倾向、预防(手术、压迫)、人工淋巴引流、体育锻炼、体重、建议以及包括基因疗法在内的治疗方法。
{"title":"New insights in breast cancer-related lymphedema","authors":"Caroline Fourgeaud,&nbsp;Stéphane Vignes","doi":"10.1016/j.jdmv.2024.06.001","DOIUrl":"10.1016/j.jdmv.2024.06.001","url":null,"abstract":"<div><p>Upper limb lymphedema<span> after breast cancer treatment including axillary dissection occurs in almost 20% of women. Its treatment consists of complete decongestive physiotherapy based on low-stretch bandage to reduce volume, followed by elastic compression to maintain it. In this article, we will detail recent data on lymphedema risk factors with possible genetic predisposition<span>, prevention (surgical, compression), manual lymphatic drainage, physical activity, weight, advice, and treatments including gene therapy.</span></span></p></div>","PeriodicalId":53149,"journal":{"name":"JMV-Journal de Medecine Vasculaire","volume":"49 3","pages":"Pages 135-140"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141704387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An isolated right renal hilum false aneurysm: A rare complication of Behçet's disease 孤立的右肾盂假性动脉瘤:贝赫切特氏病的罕见并发症
Q3 Medicine Pub Date : 2024-09-01 DOI: 10.1016/j.jdmv.2024.07.003
Hajar El Bhali , Amine Azghari

Behçet's disease is a systemic vasculitis of unknown origin. It mainly affects young men. Vascular involvement mainly affects the veins and may manifest as deep or superficial thrombosis. Arterial involvement is rare and serious. Arterial thrombosis or aneurysms/false aneurysms can be life threatening in case of rupture. All the arteries in the body can be affected, with widely varying frequencies. Involvement of the renal arteries is very rare. We report the case of a young patient followed for schizophrenia and known to have Behçet's disease, in whom a false aneurysm of the right renal artery was diagnosed during hematuria. He unfortunately refused any type of intervention.

贝赫切特病是一种原因不明的全身性血管炎。它主要影响年轻男性。血管受累主要影响静脉,可表现为深层或浅层血栓形成。动脉受累罕见且严重。动脉血栓或动脉瘤/假性动脉瘤一旦破裂可危及生命。全身所有动脉都可能受累,受累的频率差异很大。肾动脉受累非常罕见。我们报告了一例年轻患者的病例,该患者因精神分裂症接受随访,已知患有贝赫切特氏病,在出现血尿时被诊断出右肾动脉假性动脉瘤。不幸的是,他拒绝接受任何类型的干预。
{"title":"An isolated right renal hilum false aneurysm: A rare complication of Behçet's disease","authors":"Hajar El Bhali ,&nbsp;Amine Azghari","doi":"10.1016/j.jdmv.2024.07.003","DOIUrl":"10.1016/j.jdmv.2024.07.003","url":null,"abstract":"<div><p>Behçet's disease is a systemic vasculitis of unknown origin. It mainly affects young men. Vascular involvement mainly affects the veins and may manifest as deep or superficial thrombosis. Arterial involvement is rare and serious. Arterial thrombosis or aneurysms/false aneurysms can be life threatening in case of rupture. All the arteries in the body can be affected, with widely varying frequencies. Involvement of the renal arteries is very rare. We report the case of a young patient followed for schizophrenia and known to have Behçet's disease, in whom a false aneurysm of the right renal artery was diagnosed during hematuria. He unfortunately refused any type of intervention.</p></div>","PeriodicalId":53149,"journal":{"name":"JMV-Journal de Medecine Vasculaire","volume":"49 3","pages":"Pages 190-192"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142228951","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unresolved questions on venous thromboembolic disease. Therapeutic management of superficial vein thrombosis (SVT). Consensus statement of the French Society for Vascular Medicine (SFMV) 静脉血栓栓塞性疾病的未解之谜。浅静脉血栓(SVT)的治疗管理。法国血管医学会(SFMV)共识声明
Q3 Medicine Pub Date : 2024-09-01 DOI: 10.1016/j.jdmv.2024.07.002
Marie-Antoinette Sevestre , Marjolaine Talbot , Laurent Bertoletti , Dominique Brisot , Paul Frappe , Jean-Luc Gillet , Pierre Ouvry , SFMV

Superficial vein thrombosis (SVT), a manifestation of venous thromboembolism (VTE), is a common condition, yet of all the types of VTE, it has been the least well studied. Recent studies have challenged the conception that SVT is a benign disease, showing that its risk factors overlap with those of deep-vein thrombosis (DVT) and that it is frequently associated with DVT or pulmonary embolism (PE). In 2010, the CALISTO trial demonstrated the benefit of treatment with fondaparinux at the dose of 2.5 mg (one injection per day) for 45 days for lower limb SVT. Prior to CALISTO, the treatment of SVT was based on venous compression therapy, nonsteroidal anti-inflammatory drugs (NSAID) and anticoagulation using various therapeutic regimens. Surgery could also be envisaged in certain cases. In CALISTO, the inclusion criteria designed to obtain a homogeneous population meant that numerous questions remained unanswered with respect to SVT occurring in other locations and under other circumstances, notably in pregnant women, patients with renal insufficiency, and patients with recurrent SVT or superficial vein thrombosis less than 5 cm long. The aim of this section is to review the current state of knowledge of SVT and to propose or recommend therapeutic strategies for the management of SVT according to the clinical context, the location of the thrombosis, and the presence of particular risk factors.

浅静脉血栓(SVT)是静脉血栓栓塞症(VTE)的一种表现形式,是一种常见病,但在所有类型的 VTE 中,对它的研究却最少。最近的研究对 SVT 是一种良性疾病的观点提出了质疑,研究表明 SVT 的风险因素与深静脉血栓形成 (DVT) 的风险因素重叠,而且 SVT 经常与 DVT 或肺栓塞 (PE) 相关。2010 年,CALISTO 试验证明了使用磺达肝癸治疗下肢 SVT 的益处,剂量为 2.5 毫克(每天注射一次),疗程为 45 天。在 CALISTO 试验之前,治疗 SVT 的方法主要是静脉加压疗法、非甾体抗炎药(NSAID)和使用各种治疗方案的抗凝疗法。在某些情况下还可考虑手术治疗。在 CALISTO 中,由于纳入标准旨在获得同质人群,因此对于在其他部位和其他情况下发生的 SVT,尤其是孕妇、肾功能不全患者、复发性 SVT 或长度小于 5 厘米的浅静脉血栓患者,仍有许多问题没有得到解答。本节旨在回顾有关 SVT 的现有知识,并根据临床情况、血栓形成的部位以及是否存在特定的危险因素,提出或建议 SVT 的治疗策略。
{"title":"Unresolved questions on venous thromboembolic disease. Therapeutic management of superficial vein thrombosis (SVT). Consensus statement of the French Society for Vascular Medicine (SFMV)","authors":"Marie-Antoinette Sevestre ,&nbsp;Marjolaine Talbot ,&nbsp;Laurent Bertoletti ,&nbsp;Dominique Brisot ,&nbsp;Paul Frappe ,&nbsp;Jean-Luc Gillet ,&nbsp;Pierre Ouvry ,&nbsp;SFMV","doi":"10.1016/j.jdmv.2024.07.002","DOIUrl":"10.1016/j.jdmv.2024.07.002","url":null,"abstract":"<div><p>Superficial vein thrombosis (SVT), a manifestation of venous thromboembolism (VTE), is a common condition, yet of all the types of VTE, it has been the least well studied. Recent studies have challenged the conception that SVT is a benign disease, showing that its risk factors overlap with those of deep-vein thrombosis (DVT) and that it is frequently associated with DVT or pulmonary embolism (PE). In 2010, the CALISTO trial demonstrated the benefit of treatment with fondaparinux at the dose of 2.5<!--> <!-->mg (one injection per day) for 45<!--> <!-->days for lower limb SVT. Prior to CALISTO, the treatment of SVT was based on venous compression therapy, nonsteroidal anti-inflammatory drugs (NSAID) and anticoagulation using various therapeutic regimens. Surgery could also be envisaged in certain cases. In CALISTO, the inclusion criteria designed to obtain a homogeneous population meant that numerous questions remained unanswered with respect to SVT occurring in other locations and under other circumstances, notably in pregnant women, patients with renal insufficiency, and patients with recurrent SVT or superficial vein thrombosis less than 5<!--> <!-->cm long. The aim of this section is to review the current state of knowledge of SVT and to propose or recommend therapeutic strategies for the management of SVT according to the clinical context, the location of the thrombosis, and the presence of particular risk factors.</p></div>","PeriodicalId":53149,"journal":{"name":"JMV-Journal de Medecine Vasculaire","volume":"49 3","pages":"Pages 162-169"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142228945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Venous recanalisation in the setting of post-thrombotic syndrome: An expert consensus from the French Society of Vascular Medicine (SFMV) and the French Society of Cardiovascular Imaging and Interventional Radiology (SFICV) 血栓后综合征情况下的静脉再通术:法国血管医学会 (SFMV) 和法国心血管成像与介入放射学会 (SFICV) 专家共识
Q3 Medicine Pub Date : 2024-09-01 DOI: 10.1016/j.jdmv.2024.06.002
Costantino Del Giudice , Guillaume Mahe , Frederic Thony , Stephane Zuily , Gilles Goyault , Antoine Diard , Romaric Loffroy , Jean-Philippe Galanaud , Francine Thouveny , Isabelle Quere , Caroline Menez , Christine Jurus , Gilles Pernod , Jean-Marc Pernes , Marc Sapoval , Post-thrombotic syndrome study group of Interventional, Cardiovascular French Society of Radiology (SFICV), French Society of Vascular Medicine (SFMV)

Several aspects of the management of post-thrombotic syndrome (PTS) are still a matter of debate, or not yet addressed in international guidelines. The objective of this expert consensus from the French Society of Vascular Medicine (SFMV) and the French Society of Cardiovascular Imaging (SFICV) was to define the main elements of diagnosis and treatment of this syndrome, and to develop a proposal for its preoperative, procedural and follow-up management. In this consensus, the following issues were addressed: clinical and ultrasound diagnosis; pre-procedural workup; indications and contraindications to venous recanalisation; procedures; clinical and duplex ultrasound reports; follow-up; long-term treatment; management of great saphenous vein incompetency; anticoagulant and antiplatelet therapy after venous stenting.

血栓后综合征(PTS)治疗的几个方面仍存在争议,或尚未在国际指南中提及。法国血管医学会(SFMV)和法国心血管造影学会(SFICV)达成的专家共识旨在明确血栓后综合征诊断和治疗的主要内容,并为术前、术中和后续管理提出建议。该共识涉及以下问题:临床和超声诊断;术前检查;静脉再通术的适应症和禁忌症;手术;临床和双相超声报告;随访;长期治疗;大隐静脉瓣膜功能不全的处理;静脉支架术后的抗凝和抗血小板治疗。
{"title":"Venous recanalisation in the setting of post-thrombotic syndrome: An expert consensus from the French Society of Vascular Medicine (SFMV) and the French Society of Cardiovascular Imaging and Interventional Radiology (SFICV)","authors":"Costantino Del Giudice ,&nbsp;Guillaume Mahe ,&nbsp;Frederic Thony ,&nbsp;Stephane Zuily ,&nbsp;Gilles Goyault ,&nbsp;Antoine Diard ,&nbsp;Romaric Loffroy ,&nbsp;Jean-Philippe Galanaud ,&nbsp;Francine Thouveny ,&nbsp;Isabelle Quere ,&nbsp;Caroline Menez ,&nbsp;Christine Jurus ,&nbsp;Gilles Pernod ,&nbsp;Jean-Marc Pernes ,&nbsp;Marc Sapoval ,&nbsp;Post-thrombotic syndrome study group of Interventional, Cardiovascular French Society of Radiology (SFICV), French Society of Vascular Medicine (SFMV)","doi":"10.1016/j.jdmv.2024.06.002","DOIUrl":"10.1016/j.jdmv.2024.06.002","url":null,"abstract":"<div><p>Several aspects of the management of post-thrombotic syndrome (PTS) are still a matter of debate, or not yet addressed in international guidelines. The objective of this expert consensus from the French Society of Vascular Medicine (SFMV) and the French Society of Cardiovascular Imaging (SFICV) was to define the main elements of diagnosis and treatment of this syndrome, and to develop a proposal for its preoperative, procedural and follow-up management. In this consensus, the following issues were addressed: clinical and ultrasound diagnosis; pre-procedural workup; indications and contraindications to venous recanalisation; procedures; clinical and duplex ultrasound reports; follow-up; long-term treatment; management of great saphenous vein incompetency; anticoagulant and antiplatelet therapy after venous stenting.</p></div>","PeriodicalId":53149,"journal":{"name":"JMV-Journal de Medecine Vasculaire","volume":"49 3","pages":"Pages 141-161"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2542451324001329/pdfft?md5=2b5c3d60b292e411f51e39d7382a80de&pid=1-s2.0-S2542451324001329-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142228944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiological, clinical, therapeutic and evolutionary specificities of the association between venous thromboembolic event and cancer in sub-Saharan Africa: Case of Togo 撒哈拉以南非洲静脉血栓栓塞事件与癌症之间关联的流行病学、临床、治疗和进化特性:多哥案例
Q3 Medicine Pub Date : 2024-04-01 DOI: 10.1016/j.jdmv.2023.12.046
Y.M. Afassinou , A.A. Adani-Ifè , Y.I. Sossou , S. Pessinaba , B. Atta , M. Pio , S. Baragou , F. Damorou

Background

Our study aimed to describe the clinical, paraclinical, therapeutic and outcomes of patients with venous thromboembolic event (VTE) associated with cancer in the context of limited resources.

Materials and methods

This was a descriptive cross-sectional study over a period of six years from March 1, 2016 to March 31, 2022, in the cardiology department and the oncology unit of the Sylvanus Olympio Teaching Hospital of Lome. Our study examined medical records of patients who were at least 18 years old and had venous thromboembolic disease and cancer that was histologically confirmed. This study did not include records that were incomplete or records from patients with coronavirus disease.

Results

Our study included 87 patients with average age of 56.36 ± 15.26 years. The discovery of VTE occurred incidentally in 28.74%. Venous thrombosis was isolated in 68.96% and proximal in 95%. Pulmonary embolism was bilateral in 77.77%. Gynaecological and urological cancers were found in 33.33% and 32.19% respectively. Adenocarcinoma was the histological type of cancer found in 47.13%. Cancers were at a very advanced stage in 74.71%. Treatment with antivitamin K was prescribed in 12.65%. In our study, there were 58 patients who passed away with a mortality rate of 66.66%. The cause of death was a complication of VTE in 22.42% and related to the course of cancer in 63.79% of cases.

Conclusion

VTE during cancer is particular with a fatal evolution due to the severity of VTE and the very advanced stage of cancer.

背景我们的研究旨在描述在资源有限的情况下,与癌症相关的静脉血栓栓塞事件(VTE)患者的临床、辅助临床、治疗和预后情况。材料和方法这是一项描述性横断面研究,从2016年3月1日至2022年3月31日的六年间,在洛美西尔瓦努斯-奥林匹奥教学医院的心脏科和肿瘤科进行。我们的研究检查了年满 18 周岁、患有静脉血栓栓塞性疾病和经组织学证实的癌症患者的医疗记录。本研究不包括不完整的病历或冠状病毒病患者的病历。28.74%的患者是偶然发现 VTE 的。68.96%的患者为孤立性静脉血栓,95%为近端静脉血栓。77.77%的患者为双侧肺栓塞。妇科癌症和泌尿科癌症分别占 33.33% 和 32.19%。47.13%的癌症组织学类型为腺癌。74.71%的癌症处于晚期。12.65% 的患者接受了抗维生素 K 治疗。在我们的研究中,有 58 名患者去世,死亡率为 66.66%。结论 由于 VTE 的严重性和癌症的晚期阶段,癌症期间的 VTE 特别具有致命性。
{"title":"Epidemiological, clinical, therapeutic and evolutionary specificities of the association between venous thromboembolic event and cancer in sub-Saharan Africa: Case of Togo","authors":"Y.M. Afassinou ,&nbsp;A.A. Adani-Ifè ,&nbsp;Y.I. Sossou ,&nbsp;S. Pessinaba ,&nbsp;B. Atta ,&nbsp;M. Pio ,&nbsp;S. Baragou ,&nbsp;F. Damorou","doi":"10.1016/j.jdmv.2023.12.046","DOIUrl":"10.1016/j.jdmv.2023.12.046","url":null,"abstract":"<div><h3>Background</h3><p>Our study aimed to describe the clinical, paraclinical, therapeutic and outcomes of patients with venous thromboembolic event (VTE) associated with cancer in the context of limited resources.</p></div><div><h3>Materials and methods</h3><p><span>This was a descriptive cross-sectional study over a period of six years from March 1, 2016 to March 31, 2022, in the cardiology<span> department and the oncology unit of the Sylvanus Olympio Teaching Hospital of Lome. Our study examined </span></span>medical records<span><span> of patients who were at least 18 years old and had venous thromboembolic disease and cancer that was histologically confirmed. This study did not include records that were incomplete or records from patients with </span>coronavirus disease.</span></p></div><div><h3>Results</h3><p>Our study included 87 patients with average age of 56.36<!--> <!-->±<!--> <span>15.26 years. The discovery of VTE occurred incidentally in 28.74%. Venous thrombosis<span> was isolated in 68.96% and proximal in 95%. Pulmonary embolism<span> was bilateral in 77.77%. Gynaecological and urological cancers<span><span> were found in 33.33% and 32.19% respectively. Adenocarcinoma was the histological type of cancer found in 47.13%. Cancers were at a very advanced stage in 74.71%. Treatment with </span>antivitamin K was prescribed in 12.65%. In our study, there were 58 patients who passed away with a mortality rate of 66.66%. The cause of death was a complication of VTE in 22.42% and related to the course of cancer in 63.79% of cases.</span></span></span></span></p></div><div><h3>Conclusion</h3><p>VTE during cancer is particular with a fatal evolution due to the severity of VTE and the very advanced stage of cancer.</p></div>","PeriodicalId":53149,"journal":{"name":"JMV-Journal de Medecine Vasculaire","volume":"49 2","pages":"Pages 72-79"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139640711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From guidelines to current practices: Suboptimal hypertension management in France. GPs’ point of view 从指导方针到现行做法:法国高血压管理的不足。全科医生的观点
Q3 Medicine Pub Date : 2024-04-01 DOI: 10.1016/j.jdmv.2024.03.002
Xavier Humbert, Julie Dupouy, Vincent Renard, Denis Pouchain, Benoit Tudrej, Henri Partouche, Nicolas Rousselot, Yves-Marie Vincent, Gladys Ibanez, Alexandre Malmartel, Maëva Jego, Serge Gilberg, Mathilde François, Emilie Ferrat, Olivier Saint-Lary, Rémy Boussageon, behalf of the Scientific Council of CNGE
{"title":"From guidelines to current practices: Suboptimal hypertension management in France. GPs’ point of view","authors":"Xavier Humbert,&nbsp;Julie Dupouy,&nbsp;Vincent Renard,&nbsp;Denis Pouchain,&nbsp;Benoit Tudrej,&nbsp;Henri Partouche,&nbsp;Nicolas Rousselot,&nbsp;Yves-Marie Vincent,&nbsp;Gladys Ibanez,&nbsp;Alexandre Malmartel,&nbsp;Maëva Jego,&nbsp;Serge Gilberg,&nbsp;Mathilde François,&nbsp;Emilie Ferrat,&nbsp;Olivier Saint-Lary,&nbsp;Rémy Boussageon,&nbsp;behalf of the Scientific Council of CNGE","doi":"10.1016/j.jdmv.2024.03.002","DOIUrl":"10.1016/j.jdmv.2024.03.002","url":null,"abstract":"","PeriodicalId":53149,"journal":{"name":"JMV-Journal de Medecine Vasculaire","volume":"49 2","pages":"Pages 118-119"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140404388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recurrent intra-cardiac thrombosis: A rare manifestation of Behçet's disease 复发性心内血栓:贝赫切特病的罕见表现
Q3 Medicine Pub Date : 2024-04-01 DOI: 10.1016/j.jdmv.2024.02.002
Abir Derbel, Mouna Snoussi, Mariem Ghribi, Mayeda Ben Hamad, Chifa Damak, Faten Frikha, Sameh Marzouk, Zouhir Bahloul

Behçet's disease is a systemic vasculitis characterized by recurrent bipolar aphtosis and ophthalmic disorders. Cardiac involvement is rarely reported and could be associated to poor prognosis. Intracardiac thrombosis is exceptional and represents a therapeutic issue. We report the case of a young man admitted in internal medicine department for management of prolonged fever and recurrent mouth ulcers.

贝赫切特氏病是一种全身性血管炎,其特点是反复发作的双极性失神和眼部疾病。很少有心脏受累的报道,这可能与预后不良有关。心内血栓是一种罕见病,也是一个治疗问题。我们报告了一例因长期发热和复发性口腔溃疡而被内科收治的年轻男性病例。
{"title":"Recurrent intra-cardiac thrombosis: A rare manifestation of Behçet's disease","authors":"Abir Derbel,&nbsp;Mouna Snoussi,&nbsp;Mariem Ghribi,&nbsp;Mayeda Ben Hamad,&nbsp;Chifa Damak,&nbsp;Faten Frikha,&nbsp;Sameh Marzouk,&nbsp;Zouhir Bahloul","doi":"10.1016/j.jdmv.2024.02.002","DOIUrl":"10.1016/j.jdmv.2024.02.002","url":null,"abstract":"<div><p>Behçet's disease is a systemic vasculitis characterized by recurrent bipolar aphtosis and ophthalmic disorders. Cardiac involvement is rarely reported and could be associated to poor prognosis. Intracardiac thrombosis is exceptional and represents a therapeutic issue. We report the case of a young man admitted in internal medicine department for management of prolonged fever and recurrent mouth ulcers.</p></div>","PeriodicalId":53149,"journal":{"name":"JMV-Journal de Medecine Vasculaire","volume":"49 2","pages":"Pages 115-117"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140406345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chronic wounds in superficial vascular malformations of lower and/or upper extremities 下肢和/或上肢浅表血管畸形的慢性伤口
Q3 Medicine Pub Date : 2024-04-01 DOI: 10.1016/j.jdmv.2024.03.006
A. Bisdorff-Bresson (Coordinatrice CNMR coordinateur Anomalies vasculaires superficielles de l’enfant et de l’adulte de l’hôpital Lariboisière) , O. Boccara
{"title":"Chronic wounds in superficial vascular malformations of lower and/or upper extremities","authors":"A. Bisdorff-Bresson (Coordinatrice CNMR coordinateur Anomalies vasculaires superficielles de l’enfant et de l’adulte de l’hôpital Lariboisière) ,&nbsp;O. Boccara","doi":"10.1016/j.jdmv.2024.03.006","DOIUrl":"https://doi.org/10.1016/j.jdmv.2024.03.006","url":null,"abstract":"","PeriodicalId":53149,"journal":{"name":"JMV-Journal de Medecine Vasculaire","volume":"49 2","pages":"Pages 63-64"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140815190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Answer to “From guidelines to current practices: Suboptimal hypertension management in France. GPs’ point of view” 回答 "从指导方针到现行做法:法国高血压管理欠佳。全科医生的观点"
Q3 Medicine Pub Date : 2024-04-01 DOI: 10.1016/j.jdmv.2024.03.001
Jean-Jacques Mourad
{"title":"Answer to “From guidelines to current practices: Suboptimal hypertension management in France. GPs’ point of view”","authors":"Jean-Jacques Mourad","doi":"10.1016/j.jdmv.2024.03.001","DOIUrl":"10.1016/j.jdmv.2024.03.001","url":null,"abstract":"","PeriodicalId":53149,"journal":{"name":"JMV-Journal de Medecine Vasculaire","volume":"49 2","pages":"Page 120"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140405575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severe ischemia due to popliteal artery occlusion in a young patient: Evidence of type 3 popliteal artery entrapment syndrome on Doppler ultrasound 一名年轻患者因腘动脉闭塞导致严重缺血:多普勒超声显示3型腘动脉夹层综合征的证据
Q3 Medicine Pub Date : 2024-04-01 DOI: 10.1016/j.jdmv.2024.01.082
Rémy Hamdan , Benoît Chapelon , Jean-Paul Kisterman , Anne-Laure Baldassini , Catherine Falchero , Nicolas Chrétien , Pierre Marx , Diane Van Der Bol Murat
{"title":"Severe ischemia due to popliteal artery occlusion in a young patient: Evidence of type 3 popliteal artery entrapment syndrome on Doppler ultrasound","authors":"Rémy Hamdan ,&nbsp;Benoît Chapelon ,&nbsp;Jean-Paul Kisterman ,&nbsp;Anne-Laure Baldassini ,&nbsp;Catherine Falchero ,&nbsp;Nicolas Chrétien ,&nbsp;Pierre Marx ,&nbsp;Diane Van Der Bol Murat","doi":"10.1016/j.jdmv.2024.01.082","DOIUrl":"10.1016/j.jdmv.2024.01.082","url":null,"abstract":"","PeriodicalId":53149,"journal":{"name":"JMV-Journal de Medecine Vasculaire","volume":"49 2","pages":"Pages 112-114"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140469087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
JMV-Journal de Medecine Vasculaire
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1